More articles from ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

You have access
Multispecific Substrate Recognition of Kidney-Specific Organic Anion Transporters OAT-K1 and OAT-K2
Ayako Takeuchi, Satohiro Masuda, Hideyuki Saito, Takaaki Abe and Ken-ichi Inui

Journal of Pharmacology and Experimental Therapeutics October 2001, 299 (1) 261-267;
You have access
Preclinical Studies to Predict the Disposition of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Humans: Characterization of in Vivo Efficacy, Pharmacokinetics, and Safety
Sean K. Kelley, Louise A. Harris, David Xie, Laura DeForge, Klara Totpal, Jeanine Bussiere and Judith A. Fox

Journal of Pharmacology and Experimental Therapeutics October 2001, 299 (1) 31-38;
You have access
Functional Characterization of Rat Organic Anion Transporter 2 in LLC-PK1 Cells
Naomi Morita, Hiroyuki Kusuhara, Takashi Sekine, Hitoshi Endou and Yuichi Sugiyama

Journal of Pharmacology and Experimental Therapeutics September 2001, 298 (3) 1179-1184;
You have access
Multidrug Resistance-Associated Protein-1 Functional Activity in Calu-3 Cells
Karen O. Hamilton, Elizabeth Topp, Irwan Makagiansar, Teruna Siahaan, Mehran Yazdanian and Kenneth L. Audus

Journal of Pharmacology and Experimental Therapeutics September 2001, 298 (3) 1199-1205;
You have access
Liposomal and Nonliposomal Drug Pharmacokinetics after Administration of Liposome-Encapsulated Vincristine and Their Contribution to Drug Tissue Distribution Properties
Rajesh Krishna, Murray S. Webb, Ginette St. Onge and Lawrence D. Mayer

Journal of Pharmacology and Experimental Therapeutics September 2001, 298 (3) 1206-1212;
You have access
Kinetics of P-Glycoprotein-Mediated Efflux of Paclitaxel
Seong Hoon Jang, M. Guillaume Wientjes and Jessie L.-S. Au

Journal of Pharmacology and Experimental Therapeutics September 2001, 298 (3) 1236-1242;
You have access
P-Glycoprotein Efflux at the Blood-Brain Barrier Mediates Differences in Brain Disposition and Pharmacodynamics between Two Structurally Related Neurokinin-1 Receptor Antagonists
Bill J. Smith, Angela C. Doran, Stafford McLean, F. David Tingley, Brian T. O'Neill and Shama M. Kajiji

Journal of Pharmacology and Experimental Therapeutics September 2001, 298 (3) 1252-1259;
You have access
Pharmacokinetics and Tissue Distribution of SB-251353, a Novel Human CXC Chemokine, after Intravenous Administration to Mice
Timothy W. Hepburn, Timothy K. Hart, Vicki L. Horton, Teresa S. Sellers, LeeAnn P. Tobia, James J. Urbanski, Wei Shi and Charles B. Davis

Journal of Pharmacology and Experimental Therapeutics September 2001, 298 (3) 886-893;
You have access
Transport Characteristics of the Anti-human Immunodeficiency Virus Nucleoside Analog, Abacavir, into Brain and Cerebrospinal Fluid
S. A. Thomas, A. Bye and M. B. Segal

Journal of Pharmacology and Experimental Therapeutics September 2001, 298 (3) 947-953;
You have access
Changes in Erythropoietin Pharmacokinetics following Busulfan-Induced Bone Marrow Ablation in Sheep: Evidence for Bone Marrow as a Major Erythropoietin Elimination Pathway
S. Chapel, P. Veng-Pedersen, R. J. Hohl, R. L. Schmidt, E. M. McGuire and J. A. Widness

Journal of Pharmacology and Experimental Therapeutics August 2001, 298 (2) 820-824;

Main menu

User menu

Search

More articles from ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Pages

Navigate

More Information

ASPET's Other Journals